Published in Bone on July 01, 2002
Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol (2006) 1.89
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab (2010) 1.87
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A (2005) 1.75
Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res (2007) 1.74
Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol (2015) 1.15
TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem (2011) 1.11
Effects of age on parathyroid hormone signaling in human marrow stromal cells. Aging Cell (2011) 0.95
The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab (2007) 0.83
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. Bone (2010) 0.82
Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice. J Bone Miner Res (2016) 0.78
Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts. J Biol Chem (2015) 0.78
Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Clin Exp Immunol (2005) 0.77
Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice. PLoS One (2015) 0.77
Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. Clin Oral Investig (2011) 0.76
Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts. Yonsei Med J (2005) 0.76
Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages. Bone (2016) 0.75
Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation. Bone Joint Res (2017) 0.75
Heterotrimeric G proteins in the control of parathyroid hormone actions. J Mol Endocrinol (2017) 0.75
The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis. J Bone Miner Metab (2016) 0.75
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology (1999) 1.89
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest (2000) 1.30
Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology (2000) 1.20
Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology (1995) 1.17
Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures. J Clin Invest (1986) 1.01
Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology (1995) 0.96
Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res (1994) 0.96
Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J Bone Miner Res (1996) 0.95
DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones. J Clin Invest (1983) 0.94
Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest (1995) 0.93
Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study. Osteoporos Int (2007) 0.92
Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology (1987) 0.92
Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women. Osteoporos Int (2011) 0.91
Cellular and molecular interactions between immune system and bone. Croat Med J (2001) 0.89
Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J Clin Invest (1987) 0.89
Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells. J Bone Miner Res (1994) 0.86
Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis. Clin Orthop Relat Res (1998) 0.85
Role of B lymphocytes in new bone formation. Lab Invest (2000) 0.84
Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures. Bone (1998) 0.83
Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J Bone Miner Res (1993) 0.83
Interleukin-1 alpha and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism. Mol Endocrinol (1990) 0.82
Standoff detection of explosives: critical comparison for ensuing options on Raman spectroscopy-LIBS sensor fusion. Anal Bioanal Chem (2011) 0.81
Divalent cation ionophores stimulate resorption and inhibit DNA synthesis in cultured fetal rat bone. Science (1981) 0.80
Effects of transforming growth factor-beta and IL-1 alpha on prostaglandin synthesis in serum-deprived osteoblastic cells. J Immunol (1991) 0.79
Interactions of hormones, ions, and drugs in the regulation of osteoclastic bone resorption. Adv Exp Med Biol (1980) 0.79
Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers. Aliment Pharmacol Ther (2002) 0.76
Effects of phosphate on calcium release, lysosomal enzyme activity in the medium, and osteoclast morphometry in cultured fetal rat bones. Metab Bone Dis Relat Res (1984) 0.76
A human periodontal ligament fibroblast clone releases a bone resorption inhibition factor in vitro. J Dent Res (1991) 0.75
Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res (1996) 0.75
[People accompanying children to pediatric visits: is something changing?]. Aten Primaria (1998) 0.75
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat. Calcif Tissue Int (1989) 0.75
Clinical assessment of metabolic bone disease. N Y State J Med (1986) 0.75
[2 years' experience in the coronary unit]. Arch Inst Cardiol Mex (1971) 0.75